USPTO serial 86004137
OPTIBODIES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 13, 2014
- Examiner
- DELGIZZI, RONALD ERNEST
- Law office
- TMEG LAW OFFICE 107
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with OPTIBODIES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Hynak
Michael J. Hynak HYNAK & ASSOCIATES, PC812 SOUTH COURTHOUSE RDARLINGTON, VA 22204-2105UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry, science and photography; chemicals used in agriculture, horticulture and forestry, namely, chemical preparations for the treatment of seeds; adhesives for industrial use; amino acids for industrial purposes; biochemicals, namely, polypeptides for in vitro research use; biochemicals namely, precursors for in vitro genetic engineering use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; stem cells for research or scientific purposes; reagents for scientific purposes; reagents for scientific or medical research use; reagents in kit form for conducting enzyme-linked immunosorbent assays, other than for medical or veterinary purposes; monoclonal antibodies for scientific use; chemical linking agents for scientific use in associating antibodies with radionuclides; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; chemical linkage compounds for scientific use in associating X-ray radiodiagnostic chemical compounds with antibodies; chemical components for producing a radio-labelled monoclonal antibody for industrial or scientific use; tagged antibodies for laboratory use; monoclonal antibodies for scientific use; reagents for scientific or medical research use; proteins for use in science; chemical preparations for use in dna analysis, other than for medical use; enzymes for scientific purposes; enzymes for technical use; enzymes, not for medical use, for detecting protein fractions; enzymes, not for medical use, for labelling protein fractions; enzymes, not for medical use, for labelling proteins; enzymes, not for medical use, for measuring protein fractions; enzymes, other than for medical use, for measuring proteins; enzymes, not for medical use, for use in detecting proteins; enzymes, not for medical or veterinary use; enzymes, not for medical use, for use in the continuous homogenous isothermal amplifications of specific dna templates; enzymes not for medical use, for use in the continuous homogenous isothermal amplifications of specific rna templates; immunological antibodies, other than for medical use; immunoglobulins, other than for medical use; Immunological antisera, other than for medical use; immunoassay reagents, other than for medical use; chemical reagents for use with immunoassay analyzers, other than for medical or veterinary use; chemicals for use in immuno-assay testing, other than medical or veterinary; tagged antibodies for laboratory use; amino acids for industrial purposes | SECTION 8 - CANCELLED | — |
| 005 | Sanitary preparations for medical purposes; dietary supplements for humans and animals; plasters, materials for dressings; disinfectants; preparations for destroying vermin, namely, fungicides and herbicides; antibodies; human immune globulin; serums; amino acids for veterinary purposes; chemical preparation for use in medical dna analysis in the nature of nucleic acids; enzymes for medical purposes; enzymes for veterinary purposes | SECTION 8 - CANCELLED | — |
| 042 | Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; laboratory services relating to the production of monoclonal antibodies; development of pharmaceutical preparations and medicines; laboratory services; research on the subject of pharmaceuticals; pharmaceutical research services; pharmaceutical research and development; pharmaceutical research and development services | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nordic BioSite AB
- Other trademarks owned by Nordic BioSite AB
- Other trademarks owned by Nordic BioSite AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named OPTIBODIES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 29, 2024 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| May 13, 2023 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Jul 30, 2020 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jul 30, 2020 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jul 29, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 13, 2020 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| May 13, 2019 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 13, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 25, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 25, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 5, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 23, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 23, 2014 | ALIE | ASSIGNED TO LIE | — |
| Dec 30, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 30, 2013 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 30, 2013 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 30, 2013 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 30, 2013 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 12, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 12, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 12, 2013 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 24, 2013 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 24, 2013 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 24, 2013 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 19, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 16, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 11, 2013 | NWAP | NEW APPLICATION ENTERED | — |